Horizon Kinetics Medical ETF (MEDX)
NASDAQ: MEDX · Real-Time Price · USD
32.56
+0.81 (2.55%)
Nov 11, 2025, 4:00 PM EST - Market closed
MEDX Holdings Information
MEDX is an equity ETF with a total of 35 individual holdings. The top holdings are Eli Lilly and Company stock at 16.59%, AbbVie at 8.99%, US BANK MMDA - USBGFS 7 at 8.91%, Novartis AG ADR at 6.48%, and Alnylam Pharmaceuticals at 5.87%.
Total Holdings
25
Top 10 Percentage
69.95%
Asset Class
Equity
ETF Category
Health
Assets
17.93M
PE Ratio
20.00
Sector Allocation
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 16.59% |
| 2 | ABBV | AbbVie Inc. | 8.99% |
| 3 | n/a | US BANK MMDA - USBGFS 7 | 8.91% |
| 4 | NVSN.MX | Novartis AG ADR | 6.48% |
| 5 | ALNY | Alnylam Pharmaceuticals, Inc. | 5.87% |
| 6 | AZN | AstraZeneca PLC | 5.19% |
| 7 | IONS | Ionis Pharmaceuticals, Inc. | 4.90% |
| 8 | JNJ | Johnson & Johnson | 4.79% |
| 9 | BMY | Bristol-Myers Squibb Company | 4.18% |
| 10 | ALKS | Alkermes plc | 4.05% |
| 11 | AMGN | Amgen Inc. | 4.04% |
| 12 | PFE | Pfizer Inc. | 3.38% |
| 13 | CRSP | CRISPR Therapeutics AG | 3.11% |
| 14 | MRK | Merck & Co., Inc. | 3.10% |
| 15 | GSK | GSK plc | 2.81% |
| 16 | BIIB | Biogen Inc. | 2.59% |
| 17 | REGN | Regeneron Pharmaceuticals, Inc. | 2.53% |
| 18 | GALT | Galectin Therapeutics Inc. | 1.49% |
| 19 | BEAM | Beam Therapeutics Inc. | 1.14% |
| 20 | NTLA | Intellia Therapeutics, Inc. | 0.73% |
| 21 | HLN | Haleon plc | 0.71% |
| 22 | SDZNY | Sandoz Group AG | 0.68% |
| 23 | REPL | Replimune Group, Inc. | 0.64% |
| 24 | VNDA | Vanda Pharmaceuticals Inc. | 0.61% |
| 25 | LTRN | Lantern Pharma Inc. | 0.53% |
As of Nov 7, 2025